In this informative Continuing Medical Education (CME) session, Georgetown University’s Adriane Fugh-Berman, director of PharmedOut, exposes the sophisticated, multi-layered tactics pharmaceutical companies use to shape doctors’ prescribing habits — far beyond obvious drug rep visits or TV ads.
Fugh-Berman details how industry leverages social psychology, key opinion leaders, medical science liaisons, sponsored medical meetings, and subtly biased continuing medical education (CME).
They use highly sophisticated, hidden marketing tools designed to influence prescribing decisions right when doctors are working or attending events — often without the doctor realising the message is coming from a drug company.
She highlights how companies build relationships through flattery, gifts, samples, and “unrestricted” educational grants that quietly steer content toward marketing messages. Even physicians who believe they are immune often fail to detect commercial bias.
This is not neutral “education” — it is a deliberate, profit-driven system that prioritizes sales over science. Psychiatry stands as one of the worst offenders. With no proven causes or cures for the expanding list of “mental disorders” in the DSM, the field relies almost entirely on symptom-suppressing drugs. Pharma’s influence — through Key Opinion Leaders promoting unproven uses, downplaying adverse effects, and framing normal human distress as chemical imbalances requiring lifelong medication — ensures a steady stream of repeat customers.
Psychiatry has been largely captured by commercial interests. This video provides clear evidence of the mechanisms behind that capture. For anyone seeking honest light on mental health, it is essential viewing: the “treatments” psychiatry pushes are too often the product of marketing, not medicine.
4. ‘Mental health’ is defined and controlled by profit-driven commercial interests
